Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070956
Filing Date
2025-05-14
Accepted
2025-05-14 08:54:06
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q iobt-20250331.htm   iXBRL 10-Q 2159471
2 EX-31.1 iobt-ex31_1.htm EX-31.1 17989
3 EX-31.2 iobt-ex31_2.htm EX-31.2 17845
4 EX-32.1 iobt-ex32_1.htm EX-32.1 10218
5 EX-32.2 iobt-ex32_2.htm EX-32.2 10077
6 GRAPHIC img135870039_0.jpg GRAPHIC 85197
7 GRAPHIC img135870039_1.jpg GRAPHIC 263655
  Complete submission text file 0000950170-25-070956.txt   8554979

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iobt-20250331.xsd EX-101.SCH 1032796
78 EXTRACTED XBRL INSTANCE DOCUMENT iobt-20250331_htm.xml XML 1094159
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41008 | Film No.: 25942949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)